
    
      The purpose of this healthy volunteer study is to provide pharmacokinetic and safety data for
      two different dose regimens of BG00012. The study will evaluate BG00012 administered over a
      24-hour period.

      The study will be conducted in male and female Chinese, Japanese, and Caucasian healthy
      volunteers.
    
  